Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katie-May McLaughlin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Diagnostics (Basel, Switzerland)|August 6, 2020
COVID-19-Related Coagulopathy-Is Transferrin a Missing Link?Katie-May McLaughlin, Marco Bechtel, Denisa Bojkova, et al.
Cells|February 28, 2020
Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to CisplatinShahana Dilruba, Alessia Grondana, Anke C Schiedel, et al.
Bioinformatics (Oxford, England)|February 9, 2021
Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviourDenisa Bojkova, Jake E McGreig, Katie-May McLaughlin, et al.
Cells|April 3, 2021
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell LineHisham Saafan, Ahmad Alahdab, Robin Michelet, et al.
Communications Biology|June 26, 2020
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabineTamara Rothenburger, Katie-May McLaughlin, Tobias Herold, et al.
Cells|November 4, 2020
Aprotinin Inhibits SARS-CoV-2 ReplicationDenisa Bojkova, Marco Bechtel, Katie-May McLaughlin, et al.
Current Issues in Molecular Biology|October 26, 2021
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 PathogenesisKatie-May McLaughlin, Denisa Bojkova, Joshua D Kandler, et al.
Cancer Letters|April 29, 2025
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkersHelen E Grimsley, Magdalena Antczak, Ian G Reddin, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 13, 2021
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsTamara Rothenburger, Dominique Thomas, Yannick Schreiber, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Diagnostics (Basel, Switzerland)|August 6, 2020
COVID-19-Related Coagulopathy-Is Transferrin a Missing Link?Katie-May McLaughlin, Marco Bechtel, Denisa Bojkova, et al.
Cells|February 28, 2020
Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to CisplatinShahana Dilruba, Alessia Grondana, Anke C Schiedel, et al.
Bioinformatics (Oxford, England)|February 9, 2021
Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviourDenisa Bojkova, Jake E McGreig, Katie-May McLaughlin, et al.
Cells|April 3, 2021
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell LineHisham Saafan, Ahmad Alahdab, Robin Michelet, et al.
Communications Biology|June 26, 2020
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabineTamara Rothenburger, Katie-May McLaughlin, Tobias Herold, et al.
Cells|November 4, 2020
Aprotinin Inhibits SARS-CoV-2 ReplicationDenisa Bojkova, Marco Bechtel, Katie-May McLaughlin, et al.
Current Issues in Molecular Biology|October 26, 2021
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 PathogenesisKatie-May McLaughlin, Denisa Bojkova, Joshua D Kandler, et al.
Cancer Letters|April 29, 2025
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkersHelen E Grimsley, Magdalena Antczak, Ian G Reddin, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 13, 2021
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cellsTamara Rothenburger, Dominique Thomas, Yannick Schreiber, et al.
Pageof 1